IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer

Pharmacologic inhibition of wild-type IDH1 with ivosidenib synergized with conventional chemotherapeutics in vitro and potentiated the efficacy of sub-therapeutic doses of these drugs in vivo in murine PDAC models.